PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
1.20
1.0–1.2 – Bare minimum. Philip Fisher would question if expansions or unforeseen costs could trigger liquidity stress.
1.20
1.0–1.2 – On the edge. Philip Fisher might worry about unexpected shortfalls or partial reliance on inventory liquidation.
1.15
1.0–1.5 – Enough cash to cover all current liabilities. Seth Klarman would check if the business routinely hoards cash or invests it.
-3518.20
Negative interest coverage suggests negative EBIT or an overbearing interest burden – a major red flag for Benjamin Graham.
-30.97
Negative short-term coverage ratio usually means negative OCF or an outsized near-term debt – a major Graham red flag.